Updated: 08/01/2014 2:21 PM
Created: 08/01/2014 2:20 PM WDIO.com
By: The Associated Press
Federal regulators have approved a new treatment from U.S. drugmaker Eli Lilly and Co. and its German counterpart, Boehringer Ingelheim, for the most common form of diabetes.
The Food and Drug Administration said Friday it will permit Jardiance tablets to be used by adult patients with type 2 diabetes who also are trying to control their condition with diet and exercise.
The drug is designed to be taken once a day to reduce a patient's blood sugar levels by blocking glucose reabsorption in the kidneys and removing excess glucose through urine. Unlike other diabetes treatments, it does not depend on a patient's insulin levels to be effective.
European Union regulators had already approved the drug, also labeled empagliflozin, in May.
Earlier this year, Lilly and Boehringer said the FDA didn't approve the drug because of concerns about the Boehringer factory in Germany where it will be made. But a Lilly spokeswoman said Friday those concerns have been resolved.
Boehringer developed the drug, and Lilly will help co-promote it.
Diabetes is a chronic condition in which the body either does not make enough insulin to break down the sugar in foods or uses insulin inefficiently. It can cause early death or serious complications like blindness, a stroke, kidney disease or heart disease when blood sugar climbs too high and damages organs and blood vessels.
Type 2 diabetes accounts for more than 90 percent of the diabetes cases diagnosed in the United States, according to the FDA.
Lilly shares fell 66 cents, or 1.1 percent, to $60.40 in afternoon trading Friday, a slightly deeper drop than broader trading indexes. Its shares have risen almost 13 percent over the past year.
(Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
Great Lakes Wolves Ordered Returned to Endangered List
A federal judge has overturned an Obama administration decision to remove the gray wolf population in the western Great Lakes region from the endangered species list.
MnDOT: Draft EIS for Relocation of Highway 53 Released
A major milestone for the relocation of Highway 53 is now available for public review.
Minnesota Health Officials Report Flu Surge
Minnesota health officials are saying there is an increase in flu outbreaks schools across the state.
UPDATED: MNsure Extends Enrollment Deadline to Dec. 31
Minnesota's health insurance exchange has extended the deadline to enroll for a second time. Minnesotans now have until Wednesday, December 31 to enroll using MNsure.
Wisconsin Budget Faces $824 million Hole
According to a new analysis released by the nonpartisan Legislative Fiscal Bureau, Wisconsin's state budget would be $824 million short to continue the current level of service.